> top > docs > PMC:7646269 > annotations

PMC:7646269 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid_Glycan-Motif-Structure

Id Subject Object Predicate Lexical cue
T1 1026-1039 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T2 5201-5214 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T3 6564-6577 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T4 14811-14824 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T5 14884-14897 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T6 15111-15124 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T7 15181-15194 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T8 15381-15394 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan
T9 16660-16673 https://glytoucan.org/Structures/Glycans/G93424OB denotes galactomannan

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 1020-1025 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T2 2533-2538 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T3 3928-3932 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T4 5195-5200 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T5 5637-5652 Body_part denotes Coronary artery http://purl.org/sig/ont/fma/fma49893
T6 6136-6141 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T7 6282-6298 Body_part denotes White blood cell http://purl.org/sig/ont/fma/fma62852
T8 6294-6298 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T9 6338-6346 Body_part denotes Platelet http://purl.org/sig/ont/fma/fma62851
T10 6513-6518 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T11 6558-6563 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T12 8310-8315 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T13 8885-8900 Body_part denotes coronary artery http://purl.org/sig/ont/fma/fma49893
T14 8942-8952 Body_part denotes renal cell http://purl.org/sig/ont/fma/fma86785
T15 8948-8952 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T16 9309-9314 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T17 9581-9586 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T18 10287-10292 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T19 10367-10371 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T20 10493-10508 Body_part denotes right lung base http://purl.org/sig/ont/fma/fma86152
T21 10655-10660 Body_part denotes chest http://purl.org/sig/ont/fma/fma9576
T22 10871-10886 Body_part denotes left lower lobe http://purl.org/sig/ont/fma/fma7371
T23 11795-11800 Body_part denotes Chest http://purl.org/sig/ont/fma/fma9576
T24 14805-14810 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T25 14878-14883 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T26 15105-15110 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T27 15175-15180 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T28 15375-15380 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083
T29 15574-15578 Body_part denotes hand http://purl.org/sig/ont/fma/fma9712
T30 16501-16506 Body_part denotes lungs http://purl.org/sig/ont/fma/fma68877
T31 16654-16659 Body_part denotes serum http://purl.org/sig/ont/fma/fma63083

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 1020-1025 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T2 2533-2538 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T3 3928-3932 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T4 5195-5200 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T5 5637-5652 Body_part denotes Coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T6 5646-5652 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T7 6136-6141 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T8 6288-6293 Body_part denotes blood http://purl.obolibrary.org/obo/UBERON_0000178
T9 6513-6518 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T10 6558-6563 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T11 8310-8315 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T12 8885-8900 Body_part denotes coronary artery http://purl.obolibrary.org/obo/UBERON_0001621
T13 8894-8900 Body_part denotes artery http://purl.obolibrary.org/obo/UBERON_0001637
T14 9309-9314 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T15 9347-9351 Body_part denotes lobe http://purl.obolibrary.org/obo/UBERON_3010752
T16 9581-9586 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T17 10287-10292 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T18 10367-10371 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T19 10430-10434 Body_part denotes lobe http://purl.obolibrary.org/obo/UBERON_3010752
T20 10493-10503 Body_part denotes right lung http://purl.obolibrary.org/obo/UBERON_0002167
T21 10499-10503 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T22 10655-10660 Body_part denotes chest http://purl.obolibrary.org/obo/UBERON_0001443
T23 10882-10886 Body_part denotes lobe http://purl.obolibrary.org/obo/UBERON_3010752
T24 11795-11800 Body_part denotes Chest http://purl.obolibrary.org/obo/UBERON_0001443
T25 14805-14810 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T26 14878-14883 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T27 15105-15110 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T28 15175-15180 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T29 15375-15380 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977
T30 15574-15578 Body_part denotes hand http://purl.obolibrary.org/obo/UBERON_0002398
T31 16654-16659 Body_part denotes serum http://purl.obolibrary.org/obo/UBERON_0001977

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 28-41 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T2 74-82 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 200-224 Disease denotes coronavirus disease‐2019 http://purl.obolibrary.org/obo/MONDO_0100096
T4 226-234 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 286-299 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T6 397-405 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T7 427-440 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T8 541-549 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T9 643-651 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 1263-1280 Disease denotes fungal infections http://purl.obolibrary.org/obo/MONDO_0002041
T11 1355-1363 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 1401-1414 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T13 1500-1524 Disease denotes coronavirus disease‐2019 http://purl.obolibrary.org/obo/MONDO_0100096
T14 1526-1534 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 1564-1583 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T16 1697-1705 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 1812-1820 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 1890-1903 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T19 1921-1929 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T20 2026-2034 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T21 2068-2081 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T22 2185-2193 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T23 2801-2814 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T24 3192-3211 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T25 3407-3415 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 3671-3677 Disease denotes Cancer http://purl.obolibrary.org/obo/MONDO_0004992
T27 3754-3761 Disease denotes Allergy http://purl.obolibrary.org/obo/MONDO_0005271
T28 3766-3776 Disease denotes Infectious http://purl.obolibrary.org/obo/MONDO_0005550
T29 3786-3793 Disease denotes Mycoses http://purl.obolibrary.org/obo/MONDO_0002041
T30 3842-3853 Disease denotes neutropenia http://purl.obolibrary.org/obo/MONDO_0001475
T31 3928-3940 Disease denotes lung disease http://purl.obolibrary.org/obo/MONDO_0005275
T32 3942-3979 Disease denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005002
T33 3962-3979 Disease denotes pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005275
T34 4439-4448 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T35 5389-5397 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T36 5449-5462 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T37 5581-5593 Disease denotes Hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T38 5611-5619 Disease denotes Diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T39 5637-5660 Disease denotes Coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T40 5646-5660 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T41 5678-5715 Disease denotes Chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005002
T42 5698-5715 Disease denotes pulmonary disease http://purl.obolibrary.org/obo/MONDO_0005275
T43 5744-5768 Disease denotes cerebrovascular accident http://purl.obolibrary.org/obo/MONDO_0005098|http://purl.obolibrary.org/obo/MONDO_0011057|http://purl.obolibrary.org/obo/MONDO_0020671
T46 5797-5803 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T47 5822-5830 Disease denotes Dementia http://purl.obolibrary.org/obo/MONDO_0001627
T48 6224-6233 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T49 7223-7231 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T50 8033-8037 Disease denotes COPD http://purl.obolibrary.org/obo/MONDO_0005002
T51 8042-8059 Disease denotes pharyngeal cancer http://purl.obolibrary.org/obo/MONDO_0005517
T52 8053-8059 Disease denotes cancer http://purl.obolibrary.org/obo/MONDO_0004992
T53 8113-8148 Disease denotes acute respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0006502
T54 8119-8148 Disease denotes respiratory distress syndrome http://purl.obolibrary.org/obo/MONDO_0009971
T55 8150-8154 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T56 8754-8756 Disease denotes he http://purl.obolibrary.org/obo/MONDO_0017319
T57 8871-8883 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T58 8885-8908 Disease denotes coronary artery disease http://purl.obolibrary.org/obo/MONDO_0005010
T59 8894-8908 Disease denotes artery disease http://purl.obolibrary.org/obo/MONDO_0000473
T60 8942-8962 Disease denotes renal cell carcinoma http://purl.obolibrary.org/obo/MONDO_0005086|http://purl.obolibrary.org/obo/MONDO_0005549
T62 8953-8962 Disease denotes carcinoma http://purl.obolibrary.org/obo/MONDO_0004993
T63 9042-9061 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T64 9737-9739 Disease denotes he http://purl.obolibrary.org/obo/MONDO_0017319
T65 10025-10044 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T66 10779-10788 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T67 10958-10974 Disease denotes thrombophlebitis http://purl.obolibrary.org/obo/MONDO_0002800
T68 11007-11017 Disease denotes bacteremia http://purl.obolibrary.org/obo/MONDO_0005229
T69 11116-11130 Disease denotes encephalopathy http://purl.obolibrary.org/obo/MONDO_0005560
T70 11132-11159 Disease denotes chronic respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T71 11221-11245 Disease denotes Staphylococcus pneumonia http://purl.obolibrary.org/obo/MONDO_0005970
T72 11236-11245 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T73 11316-11318 Disease denotes he http://purl.obolibrary.org/obo/MONDO_0017319
T74 11414-11438 Disease denotes type 2 diabetes mellitus http://purl.obolibrary.org/obo/MONDO_0005148
T75 11421-11429 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T76 11518-11537 Disease denotes respiratory failure http://purl.obolibrary.org/obo/MONDO_0021113
T77 12056-12069 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T78 12090-12098 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T79 12251-12255 Disease denotes ARDS http://purl.obolibrary.org/obo/MONDO_0006502
T80 12263-12272 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T81 12341-12349 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 12419-12427 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 12449-12462 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T84 12464-12468 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T85 12554-12562 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T86 12684-12692 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T87 12826-12835 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T88 12843-12847 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T89 12939-12947 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T90 12976-12989 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T91 13157-13165 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T92 13217-13233 Disease denotes fungal infection http://purl.obolibrary.org/obo/MONDO_0002041
T93 13224-13233 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T94 13338-13354 Disease denotes fungal infection http://purl.obolibrary.org/obo/MONDO_0002041
T95 13345-13354 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T96 13702-13723 Disease denotes respiratory infection http://purl.obolibrary.org/obo/MONDO_0024355
T97 13714-13723 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T98 13762-13771 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T99 13900-13908 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T100 14091-14099 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T101 14723-14731 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T102 14919-14941 Disease denotes invasive aspergillosis http://purl.obolibrary.org/obo/MONDO_0000240
T103 14928-14941 Disease denotes aspergillosis http://purl.obolibrary.org/obo/MONDO_0005657
T104 15050-15054 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T105 15248-15257 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T106 15298-15307 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T107 15332-15336 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T108 15399-15403 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T109 15555-15559 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T110 15695-15703 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T111 15861-15865 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T112 15979-15987 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T113 16137-16145 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T114 16159-16176 Disease denotes fungal infections http://purl.obolibrary.org/obo/MONDO_0002041
T115 16228-16238 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T116 16335-16339 Disease denotes CAPA http://purl.obolibrary.org/obo/MONDO_0007163
T117 16375-16383 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096
T118 16750-16758 Disease denotes COVID‐19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 444-445 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 491-492 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 612-613 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T4 896-900 http://purl.obolibrary.org/obo/UBERON_0003101 denotes male
T5 896-900 http://www.ebi.ac.uk/efo/EFO_0000970 denotes male
T6 952-953 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 979-983 http://purl.obolibrary.org/obo/CLO_0053001 denotes 1‐14
T8 1174-1175 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T9 1421-1424 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T10 1769-1770 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 1931-1937 http://purl.obolibrary.org/obo/CLO_0001302 denotes 3 , 4
T12 1953-1956 http://purl.obolibrary.org/obo/PR_000001343 denotes aim
T13 2085-2086 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T14 2149-2150 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T15 2281-2283 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T16 2533-2538 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T17 2695-2696 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T18 3376-3377 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T19 3628-3640 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T20 3913-3914 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 3928-3932 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T22 3928-3932 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T23 5021-5022 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 5048-5052 http://purl.obolibrary.org/obo/CLO_0053001 denotes 1‐14
T25 5538-5542 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T26 5538-5542 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T27 5544-5548 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T28 5544-5548 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T29 5550-5554 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T30 5550-5554 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T31 5556-5560 http://purl.obolibrary.org/obo/UBERON_0003101 denotes Male
T32 5556-5560 http://www.ebi.ac.uk/efo/EFO_0000970 denotes Male
T33 5646-5652 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T34 5646-5652 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T35 6136-6141 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T36 6288-6293 http://www.ebi.ac.uk/efo/EFO_0000296 denotes blood
T37 6294-6298 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T38 7559-7560 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T39 7816-7820 http://purl.obolibrary.org/obo/CLO_0001006 denotes 3‐11
T40 7832-7833 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T41 8020-8021 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 8308-8309 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T43 8310-8315 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T44 8835-8836 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T45 8858-8859 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 8894-8900 http://purl.obolibrary.org/obo/UBERON_0001637 denotes artery
T47 8894-8900 http://www.ebi.ac.uk/efo/EFO_0000814 denotes artery
T48 8948-8952 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T49 9307-9308 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T50 9309-9314 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T51 9572-9573 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T52 9581-9586 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T53 9930-9931 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T54 10080-10081 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T55 10285-10286 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T56 10287-10292 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T57 10367-10371 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T58 10367-10371 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T59 10493-10503 http://purl.obolibrary.org/obo/UBERON_0002167 denotes right lung
T60 10646-10647 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T61 10655-10660 http://www.ebi.ac.uk/efo/EFO_0000965 denotes chest
T62 10827-10828 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T63 11061-11062 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T64 11254-11255 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T65 11378-11379 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T66 11401-11402 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T67 11795-11800 http://www.ebi.ac.uk/efo/EFO_0000965 denotes Chest
T68 12810-12815 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T69 13244-13247 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T70 13268-13269 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T71 13307-13308 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T72 14268-14270 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T73 14965-14968 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T74 15311-15312 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T75 15677-15678 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T76 16305-16306 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T77 16345-16346 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T78 16501-16506 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lungs
T79 16605-16606 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T80 16652-16653 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 301-304 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T3 840-843 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T5 896-900 Chemical denotes male http://purl.obolibrary.org/obo/CHEBI_30780
T6 1026-1039 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T7 1137-1152 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T8 1416-1419 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T10 1736-1751 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T11 1791-1794 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T13 2436-2442 Chemical denotes oxygen http://purl.obolibrary.org/obo/CHEBI_25805
T14 2662-2672 Chemical denotes prednisone http://purl.obolibrary.org/obo/CHEBI_8382
T15 2834-2837 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T17 2984-2994 Chemical denotes antibiotic http://purl.obolibrary.org/obo/CHEBI_33281
T18 3034-3045 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T19 3589-3592 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T21 3813-3816 Chemical denotes MSG http://purl.obolibrary.org/obo/CHEBI_64220|http://purl.obolibrary.org/obo/CHEBI_64243
T23 3875-3890 Chemical denotes corticosteroids http://purl.obolibrary.org/obo/CHEBI_50858
T24 4153-4163 Chemical denotes antibiotic http://purl.obolibrary.org/obo/CHEBI_33281
T25 4211-4225 Chemical denotes glucocorticoid http://purl.obolibrary.org/obo/CHEBI_24261
T26 4241-4251 Chemical denotes prednisone http://purl.obolibrary.org/obo/CHEBI_8382
T27 4781-4784 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T29 5201-5214 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T30 5317-5327 Chemical denotes antibiotic http://purl.obolibrary.org/obo/CHEBI_33281
T31 6428-6439 Chemical denotes Lactic acid http://purl.obolibrary.org/obo/CHEBI_28358|http://purl.obolibrary.org/obo/CHEBI_78320
T33 6435-6439 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T34 6475-6484 Chemical denotes bilirubin http://purl.obolibrary.org/obo/CHEBI_16990
T35 6519-6529 Chemical denotes creatinine http://purl.obolibrary.org/obo/CHEBI_16737
T36 6564-6577 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T37 6579-6581 Chemical denotes NA http://purl.obolibrary.org/obo/CHEBI_33696
T38 6705-6715 Chemical denotes prednisone http://purl.obolibrary.org/obo/CHEBI_8382
T39 6880-6888 Chemical denotes Cefepime http://purl.obolibrary.org/obo/CHEBI_478164
T40 6891-6901 Chemical denotes Vancomycin http://purl.obolibrary.org/obo/CHEBI_28001
T41 6903-6911 Chemical denotes Cefepime http://purl.obolibrary.org/obo/CHEBI_478164
T42 6914-6924 Chemical denotes Vancomycin http://purl.obolibrary.org/obo/CHEBI_28001
T43 6926-6935 Chemical denotes Meropenem http://purl.obolibrary.org/obo/CHEBI_43968
T44 6938-6948 Chemical denotes Vancomycin http://purl.obolibrary.org/obo/CHEBI_28001
T45 6950-6958 Chemical denotes Cefepime http://purl.obolibrary.org/obo/CHEBI_478164
T46 6961-6971 Chemical denotes Vancomycin http://purl.obolibrary.org/obo/CHEBI_28001
T47 7034-7045 Chemical denotes Caspofungin http://purl.obolibrary.org/obo/CHEBI_474180
T48 7099-7101 Chemical denotes NA http://purl.obolibrary.org/obo/CHEBI_33696
T49 7490-7505 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T50 7546-7554 Chemical denotes steroids http://purl.obolibrary.org/obo/CHEBI_35341
T51 7676-7690 Chemical denotes glucocorticoid http://purl.obolibrary.org/obo/CHEBI_24261
T52 7771-7785 Chemical denotes glucocorticoid http://purl.obolibrary.org/obo/CHEBI_24261
T53 7850-7860 Chemical denotes prednisone http://purl.obolibrary.org/obo/CHEBI_8382
T54 7929-7940 Chemical denotes tocilizumab http://purl.obolibrary.org/obo/CHEBI_64360
T55 8397-8405 Chemical denotes cefepime http://purl.obolibrary.org/obo/CHEBI_478164
T56 8410-8420 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T58 8543-8554 Chemical denotes antibiotics http://purl.obolibrary.org/obo/CHEBI_33281
T59 8559-8571 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T60 8801-8811 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T61 9474-9482 Chemical denotes cefepime http://purl.obolibrary.org/obo/CHEBI_478164
T62 9487-9497 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T64 9696-9705 Chemical denotes meropenem http://purl.obolibrary.org/obo/CHEBI_43968
T65 9707-9717 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T67 9723-9735 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T68 9896-9906 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T69 10203-10212 Chemical denotes meropenem http://purl.obolibrary.org/obo/CHEBI_43968
T70 10217-10227 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T72 10261-10273 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T73 10504-10508 Chemical denotes base http://purl.obolibrary.org/obo/CHEBI_22695
T74 10580-10592 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T75 10681-10693 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T76 11042-11052 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T78 11344-11354 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T79 11576-11584 Chemical denotes cefepime http://purl.obolibrary.org/obo/CHEBI_478164
T80 11589-11599 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T82 11852-11863 Chemical denotes Caspofungin http://purl.obolibrary.org/obo/CHEBI_474180
T83 11890-11899 Chemical denotes meropenem http://purl.obolibrary.org/obo/CHEBI_43968
T84 11904-11914 Chemical denotes vancomycin http://purl.obolibrary.org/obo/CHEBI_28001|http://purl.obolibrary.org/obo/CHEBI_76842
T86 12000-12010 Chemical denotes antifungal http://purl.obolibrary.org/obo/CHEBI_35718
T87 12587-12590 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T89 12611-12614 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T91 12895-12898 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T93 13488-13491 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T95 14164-14167 Chemical denotes MSG http://purl.obolibrary.org/obo/CHEBI_64220|http://purl.obolibrary.org/obo/CHEBI_64243
T97 14412-14415 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T99 14529-14532 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T101 14638-14641 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T103 14811-14824 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T104 14884-14897 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T105 14947-14951 Chemical denotes beta http://purl.obolibrary.org/obo/CHEBI_10545
T106 14954-14960 Chemical denotes glucan http://purl.obolibrary.org/obo/CHEBI_37163
T107 15111-15124 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T108 15181-15194 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T109 15381-15394 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T110 15457-15460 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T112 15649-15652 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T114 15661-15664 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T116 15736-15739 Chemical denotes IPA http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802
T118 15876-15889 Chemical denotes dexamethasone http://purl.obolibrary.org/obo/CHEBI_41879
T119 16049-16064 Chemical denotes glucocorticoids http://purl.obolibrary.org/obo/CHEBI_24261
T120 16660-16673 Chemical denotes galactomannan http://purl.obolibrary.org/obo/CHEBI_27680
T121 16917-16923 Chemical denotes formal http://purl.obolibrary.org/obo/CHEBI_48341

LitCovid-PD-GlycoEpitope

Id Subject Object Predicate Lexical cue glyco_epitope_db_id
T1 1026-1039 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T2 5201-5214 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T3 6564-6577 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T4 14811-14824 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T5 14884-14897 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T6 15111-15124 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T7 15181-15194 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T8 15381-15394 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510
T9 16660-16673 GlycoEpitope denotes galactomannan http://www.glycoepitope.jp/epitopes/EP0510

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 9-41 Phenotype denotes invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T2 267-299 Phenotype denotes invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T3 301-304 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T4 840-843 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T5 1382-1414 Phenotype denotes Invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T6 1416-1419 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T7 1564-1583 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T8 1791-1794 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T9 2674-2679 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T10 2834-2837 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T11 2919-2924 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T12 2940-2945 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T13 3019-3024 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T14 3192-3211 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T15 3589-3592 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T16 3671-3677 Phenotype denotes Cancer http://purl.obolibrary.org/obo/HP_0002664
T17 3679-3705 Phenotype denotes Invasive Fungal Infections http://purl.obolibrary.org/obo/HP_0020101
T18 3754-3761 Phenotype denotes Allergy http://purl.obolibrary.org/obo/HP_0012393
T19 3842-3853 Phenotype denotes neutropenia http://purl.obolibrary.org/obo/HP_0001875
T20 3928-3940 Phenotype denotes lung disease http://purl.obolibrary.org/obo/HP_0002088
T21 3942-3979 Phenotype denotes chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/HP_0006510
T22 4035-4040 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T23 4107-4132 Phenotype denotes respiratory insufficiency http://purl.obolibrary.org/obo/HP_0002093
T24 4439-4448 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T25 4781-4784 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T26 5115-5120 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T27 5125-5137 Phenotype denotes leukocytosis http://purl.obolibrary.org/obo/HP_0001974
T28 5430-5462 Phenotype denotes invasive pulmonary aspergillosis http://purl.obolibrary.org/obo/HP_0020103
T29 5581-5593 Phenotype denotes Hypertension http://purl.obolibrary.org/obo/HP_0000822
T30 5678-5715 Phenotype denotes Chronic obstructive pulmonary disease http://purl.obolibrary.org/obo/HP_0006510
T31 5744-5768 Phenotype denotes cerebrovascular accident http://purl.obolibrary.org/obo/HP_0001297
T32 5797-5803 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T33 5822-5830 Phenotype denotes Dementia http://purl.obolibrary.org/obo/HP_0000726
T34 6015-6020 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T35 6224-6233 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T36 8033-8037 Phenotype denotes COPD http://purl.obolibrary.org/obo/HP_0006510
T37 8053-8059 Phenotype denotes cancer http://purl.obolibrary.org/obo/HP_0002664
T38 8119-8139 Phenotype denotes respiratory distress http://purl.obolibrary.org/obo/HP_0002098
T39 8167-8172 Phenotype denotes shock http://purl.obolibrary.org/obo/HP_0031273
T40 8502-8514 Phenotype denotes Leukocytosis http://purl.obolibrary.org/obo/HP_0001974
T41 8586-8604 Phenotype denotes intermittent fever http://purl.obolibrary.org/obo/HP_0001954
T42 8871-8883 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T43 8910-8936 Phenotype denotes transient ischaemic attack http://purl.obolibrary.org/obo/HP_0002326
T44 8942-8962 Phenotype denotes renal cell carcinoma http://purl.obolibrary.org/obo/HP_0005584
T45 9042-9061 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T46 9403-9420 Phenotype denotes pneumomediastinum http://purl.obolibrary.org/obo/HP_0025421
T47 9781-9793 Phenotype denotes leukocytosis http://purl.obolibrary.org/obo/HP_0001974
T48 10025-10044 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T49 10082-10087 Phenotype denotes fever http://purl.obolibrary.org/obo/HP_0001945
T50 10229-10234 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T51 10599-10604 Phenotype denotes Fever http://purl.obolibrary.org/obo/HP_0001945
T52 10609-10621 Phenotype denotes leukocytosis http://purl.obolibrary.org/obo/HP_0001974
T53 10779-10788 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T54 10958-10974 Phenotype denotes thrombophlebitis http://purl.obolibrary.org/obo/HP_0004418
T55 11007-11017 Phenotype denotes bacteremia http://purl.obolibrary.org/obo/HP_0031864
T56 11116-11130 Phenotype denotes encephalopathy http://purl.obolibrary.org/obo/HP_0001298
T57 11140-11159 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T58 11236-11245 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T59 11421-11438 Phenotype denotes diabetes mellitus http://purl.obolibrary.org/obo/HP_0000819
T60 11518-11537 Phenotype denotes respiratory failure http://purl.obolibrary.org/obo/HP_0002878
T61 12587-12590 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T62 12611-12614 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T63 12826-12835 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T64 12895-12898 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T65 13329-13354 Phenotype denotes invasive fungal infection http://purl.obolibrary.org/obo/HP_0020101
T66 13405-13411 Phenotype denotes sepsis http://purl.obolibrary.org/obo/HP_0100806
T67 13488-13491 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T68 13702-13723 Phenotype denotes respiratory infection http://purl.obolibrary.org/obo/HP_0011947
T69 14412-14415 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T70 14529-14532 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T71 14638-14641 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T72 15288-15307 Phenotype denotes pulmonary infection http://purl.obolibrary.org/obo/HP_0006532
T73 15457-15460 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T74 15649-15652 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T75 15661-15664 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T76 15736-15739 Phenotype denotes IPA http://purl.obolibrary.org/obo/HP_0020103
T77 16480-16506 Phenotype denotes abnormalities of the lungs http://purl.obolibrary.org/obo/HP_0002088

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-83 Sentence denotes Putative invasive pulmonary aspergillosis in critically ill patients with COVID‐19:
T2 84-125 Sentence denotes An observational study from New York City
T3 126-139 Sentence denotes MITAKA et al.
T4 141-149 Sentence denotes Abstract
T5 150-158 Sentence denotes Abstract
T6 160-170 Sentence denotes Background
T7 171-332 Sentence denotes Critically ill patients with coronavirus disease‐2019 (COVID‐19) are at the theoretical risk of invasive pulmonary aspergillosis (IPA) due to known risk factors.
T8 334-350 Sentence denotes Patients/Methods
T9 351-477 Sentence denotes We aimed to describe the clinical features of COVID‐19‐associated pulmonary aspergillosis at a single centre in New York City.
T10 478-602 Sentence denotes We performed a retrospective chart review of all patients with COVID‐19 with Aspergillus isolated from respiratory cultures.
T11 604-611 Sentence denotes Results
T12 612-797 Sentence denotes A total of seven patients with COVID‐19 who had one or more positive respiratory cultures for Aspergillus fumigatus were identified, all of whom were mechanically ventilated in the ICU.
T13 798-844 Sentence denotes Four patients were classified as putative IPA.
T14 845-901 Sentence denotes The median age was 79 years, and all patients were male.
T15 902-978 Sentence denotes The patients had been mechanically ventilated for a mean of 6.8 days (range:
T16 979-1019 Sentence denotes 1‐14 days) before Aspergillus isolation.
T17 1020-1080 Sentence denotes Serum galactomannan level was positive for only one patient.
T18 1081-1201 Sentence denotes The majority of our cases received much higher doses of glucocorticoids than the dosage with a proven mortality benefit.
T19 1202-1225 Sentence denotes All four patients died.
T20 1227-1238 Sentence denotes Conclusions
T21 1239-1364 Sentence denotes Vigilance for secondary fungal infections will be needed to reduce adverse outcomes in critically ill patients with COVID‐19.
T22 1366-1381 Sentence denotes 1 INTRODUCTION
T23 1382-1477 Sentence denotes Invasive pulmonary aspergillosis (IPA) has been reported in critically ill patients in the ICU.
T24 1478-1666 Sentence denotes 1 , 2 Patients with coronavirus disease‐2019 (COVID‐19) may develop acute hypoxemic respiratory failure and are at high risk of requiring mechanical ventilation with prolonged ICU stays.
T25 1667-1752 Sentence denotes Further, patients with severe COVID‐19 may be administered high‐dose glucocorticoids.
T26 1753-1856 Sentence denotes Hence, there is a theoretical risk of IPA in patients with COVID‐19 due to combined known risk factors.
T27 1857-1930 Sentence denotes However, there are scant data on aspergillosis in patients with COVID‐19.
T28 1931-2110 Sentence denotes 3 , 4 , 5 , 6 The aim of the study was to describe the clinical features of critically ill COVID‐19‐infected patients with pulmonary aspergillosis at a New York City hospital.
T29 2112-2135 Sentence denotes 2 PATIENTS AND METHODS
T30 2136-2363 Sentence denotes We performed a retrospective chart review of all COVID‐19‐infected patients with Aspergillus isolates in respiratory samples during 21 March and 22 April 2020 at Mount Sinai Beth Israel, an acute care hospital in New York City.
T31 2364-2525 Sentence denotes We collected longitudinal clinical data, including fraction of inspired oxygen (FiO2) and vital signs, laboratory and microbiology data, treatment, and outcomes.
T32 2526-2600 Sentence denotes Serial chest radiographs and computed tomography (CT) scans were reviewed.
T33 2601-2673 Sentence denotes Glucocorticoid dose was converted into an equivalent dose of prednisone.
T34 2674-2730 Sentence denotes Fever was defined as a temperature of ≥100.4 Fahrenheit.
T35 2731-2873 Sentence denotes We used the clinical algorithm for ICU patients to classify pulmonary aspergillosis as either putative IPA or colonisation (AspICU algorithm).
T36 2874-3075 Sentence denotes 7 As per the clinical algorithm, persistent fever was defined as fever persisting despite at least 3 days of antibiotic therapy or recrudescent fever while on antibiotics without other apparent cause.
T37 3076-3251 Sentence denotes Worsening respiratory status was defined by an increase in FiO2 requirement on mechanical ventilation, or worsening respiratory failure led to invasive mechanical ventilation.
T38 3252-3363 Sentence denotes Study approval was obtained from the institutional review board of the Icahn School of Medicine at Mount Sinai.
T39 3365-3375 Sentence denotes 3 RESULTS
T40 3376-3508 Sentence denotes A total of seven patients with COVID‐19 who had one or more positive respiratory cultures for Aspergillus fumigatus were identified.
T41 3509-3593 Sentence denotes According to the AspICU algorithm, 7 four patients were classified as putative IPA.
T42 3594-3891 Sentence denotes None of the patients had European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) host factors, including neutropenia and prolonged use of corticosteroids.
T43 3892-3994 Sentence denotes Only one patient had a pre‐existing lung disease (chronic obstructive pulmonary disease in Patient 1).
T44 3995-4309 Sentence denotes All four patients had compatible signs (fever refractory to at least 3 days of appropriate therapy or worsening respiratory insufficiency despite appropriate antibiotic therapy and ventilatory support), host factor (glucocorticoid treatment with prednisone equivalent > 20 mg/d) and abnormal radiographic findings.
T45 4310-4524 Sentence denotes Radiographic abnormalities included worsening infiltrates (Patient 1), opacities with dense consolidations (Patient 2), cavitary pneumonia (Patient 3) and diffuse interstitial and patchy hazy opacities (Patient 4).
T46 4525-4634 Sentence denotes The remaining three patients were classified as having colonisation as they lacked compatible clinical signs.
T47 4635-4725 Sentence denotes For those three patients, subsequent clinical deterioration was explained by other causes.
T48 4726-4806 Sentence denotes Clinical characteristics of the patients with putative IPA are shown in Table 1.
T49 4807-4835 Sentence denotes The median age was 79 years.
T50 4836-4970 Sentence denotes All experienced worsening respiratory status leading to invasive mechanical ventilation before the isolation of Aspergillus fumigatus.
T51 4971-5047 Sentence denotes The patients had been mechanically ventilated for a mean of 6.8 days (range:
T52 5048-5088 Sentence denotes 1‐14 days) before Aspergillus isolation.
T53 5089-5194 Sentence denotes At Aspergillus isolation, fever and leukocytosis were present in one and all four patients, respectively.
T54 5195-5267 Sentence denotes Serum galactomannan level was positive for only one patient (Patient 2).
T55 5268-5336 Sentence denotes All patients received concomitant broad‐spectrum antibiotic therapy.
T56 5337-5462 Sentence denotes Table 1 Clinical characteristics of critically ill COVID‐19‐infected patients with putative invasive pulmonary aspergillosis
T57 5463-5505 Sentence denotes Patient 1 Patient 2 Patient 3 Patient 4
T58 5506-5529 Sentence denotes Age (y) 82 79 77 77
T59 5530-5560 Sentence denotes Gender Male Male Male Male
T60 5561-5580 Sentence denotes Comorbid conditions
T61 5581-5610 Sentence denotes Hypertension No Yes No No
T62 5611-5636 Sentence denotes Diabetes No No No Yes
T63 5637-5677 Sentence denotes Coronary artery disease No Yes No No
T64 5678-5732 Sentence denotes Chronic obstructive pulmonary disease Yes No No No
T65 5733-5785 Sentence denotes History of cerebrovascular accident No Yes No No
T66 5786-5821 Sentence denotes History of cancer Yes Yes No No
T67 5822-5846 Sentence denotes Dementia No No No No
T68 5847-5971 Sentence denotes Timing of positive culture for Aspergillus fumigatus (hospital day) Day 15 and 20 Day 7, 10, and 16 Day 10 and 14 Day 10
T69 5972-6014 Sentence denotes Clinical features at Aspergillus isolation
T70 6015-6037 Sentence denotes Fever No No Yes No
T71 6038-6101 Sentence denotes Respiratory status at Aspergillus isolation IMV IMV IMV IMV
T72 6102-6281 Sentence denotes New radiographic abnormalities on chest CT or X‐ray Worsening infiltrates Opacities with dense consolidations Cavitary pneumonia Diffuse interstitial and patchy hazy opacities
T73 6282-6337 Sentence denotes White blood cell count (103/μL) 32.9 21.1 20.1 20.2
T74 6338-6381 Sentence denotes Platelet count (103/μL) 376 146 420 123
T75 6382-6427 Sentence denotes Procalcitonin (ng/mL) 0.16 0.30 3.30 9.34
T76 6428-6468 Sentence denotes Lactic acid (mmol/L) 1.0 3.6 1.6 3.7
T77 6469-6512 Sentence denotes Total bilirubin (mg/dL) 2.4 1.1 1.4 2.9
T78 6513-6557 Sentence denotes Serum creatinine (mg/dL) 2.6 3.1 1.5 4.1
T79 6558-6607 Sentence denotes Serum galactomannan NA 0.71 Negative Negative
T80 6608-6647 Sentence denotes Vasopressor support Yes Yes Yes Yes
T81 6648-6669 Sentence denotes Inpatient medications
T82 6670-6685 Sentence denotes Glucocorticoids
T83 6686-6751 Sentence denotes Cumulative dose in prednisone equivalent (mg) 932 1000 870 87
T84 6752-6809 Sentence denotes Starting date (hospital day) Day 8 Day 2 Day 2 Day 10
T85 6810-6837 Sentence denotes Duration (d) 10 10 12 3
T86 6838-6866 Sentence denotes Tocilizumab No Yes No No
T87 6867-6971 Sentence denotes Antibiotics Cefepime + Vancomycin Cefepime + Vancomycin Meropenem + Vancomycin Cefepime + Vancomycin
T88 6972-7045 Sentence denotes Antifungal therapy Voriconazole Voriconazole Voriconazole Caspofungin
T89 7046-7117 Sentence denotes Abbreviations: IMV, invasive mechanical ventilation; NA, not available.
T90 7118-7265 Sentence denotes John Wiley & Sons, Ltd This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response.
T91 7266-7448 Sentence denotes It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.
T92 7449-7585 Sentence denotes All four patients concomitantly received glucocorticoids, with three of which were already given steroids for a mean of 6.6 days (range:
T93 7586-7632 Sentence denotes 5‐8 days) before the isolation of Aspergillus.
T94 7633-7741 Sentence denotes In the remaining one patient (patients 4), glucocorticoid therapy was administered at Aspergillus isolation.
T95 7742-7815 Sentence denotes The overall mean duration of glucocorticoid exposure was 8.5 days (range:
T96 7816-7894 Sentence denotes 3‐11 days) with a mean cumulative prednisone equivalent dose of 722 mg (range:
T97 7895-7907 Sentence denotes 87‐1000 mg).
T98 7908-7981 Sentence denotes One patient received tocilizumab after Aspergillus isolation (Patient 3).
T99 7982-8173 Sentence denotes Patient 1 was an 82‐year‐old man with a history of COPD and pharyngeal cancer who was transferred to the ICU on hospital day 3 for acute respiratory distress syndrome (ARDS) and septic shock.
T100 8174-8307 Sentence denotes He was afebrile at Aspergillus isolation on hospital day 15, but respiratory status deteriorated with increased FiO2 from 50% to 80%.
T101 8308-8366 Sentence denotes A chest radiograph showed worsening bilateral infiltrates.
T102 8367-8421 Sentence denotes He was initially treated with cefepime and vancomycin.
T103 8422-8501 Sentence denotes Voriconazole was added 3 days after the first positive culture for Aspergillus.
T104 8502-8572 Sentence denotes Leukocytosis persisted on broad‐spectrum antibiotics and voriconazole.
T105 8573-8682 Sentence denotes He developed intermittent fever with worsening respiratory status and required continued vasopressor support.
T106 8683-8820 Sentence denotes The family subsequently requested no further aggressive treatment, and he passed away 17 days after the initiation of antifungal therapy.
T107 8821-9110 Sentence denotes Patient 2 was a 79‐year‐old man with a history of hypertension, coronary artery disease, transient ischaemic attack, and renal cell carcinoma who was transferred to the ICU on hospital day 6 for worsening acute hypoxemic respiratory failure requiring intubation and mechanical ventilation.
T108 9111-9232 Sentence denotes He was afebrile and had been on non‐invasive ventilation (NIV) for 6 days before Aspergillus isolation on hospital day 7.
T109 9233-9306 Sentence denotes Respiratory culture grew Aspergillus fumigatus and Staphylococcus aureus.
T110 9307-9443 Sentence denotes A chest CT showed dense bilateral lower lobe consolidations, multifocal ground‐glass opacities, pneumomediastinum and pneumopericardium.
T111 9444-9498 Sentence denotes He was initially treated with cefepime and vancomycin.
T112 9499-9571 Sentence denotes Voriconazole was started at the second positive culture for Aspergillus.
T113 9572-9661 Sentence denotes A repeat chest CT showed similar findings together with worsening ground‐glass opacities.
T114 9662-9852 Sentence denotes Despite subsequent treatment with meropenem, vancomycin, and voriconazole, he continued to deteriorate with persistent leukocytosis, worsening respiratory status, and multiorgan dysfunction.
T115 9853-9915 Sentence denotes He expired 13 days after the initiation of antifungal therapy.
T116 9916-10066 Sentence denotes Patient 3 was a 77‐year‐old man with no past medical history who was admitted to the ICU for acute hypoxemic respiratory failure requiring intubation.
T117 10067-10132 Sentence denotes He developed a fever at Aspergillus isolation on hospital day 10.
T118 10133-10172 Sentence denotes Respiratory status had remained stable.
T119 10173-10228 Sentence denotes He was initially treated with meropenem and vancomycin.
T120 10229-10284 Sentence denotes Fever persisted for 4 days, and voriconazole was added.
T121 10285-10554 Sentence denotes A chest CT showed bilateral patchy ground‐glass opacities, bilateral mid to lower lung zone predominant consolidative opacities, bilateral lower lobe cavitary lesions, the largest of which is seen within the right lung base and one of which contains an air‐fluid level.
T122 10555-10598 Sentence denotes He was then treated with voriconazole only.
T123 10599-10645 Sentence denotes Fever and leukocytosis subsided within 6 days.
T124 10646-10887 Sentence denotes A repeat chest CT after 2 weeks of voriconazole showed improved bilateral ground‐glass opacities, stable to mildly improved cavitary pneumonia within the bilateral lower lobes, and a new cavitary lesion within the subpleural left lower lobe.
T125 10888-11053 Sentence denotes The subsequent course was complicated by intravenous catheter‐related thrombophlebitis with Staphylococcus epidermidis bacteremia, which was treated with vancomycin.
T126 11054-11246 Sentence denotes He had a protracted hospital course with persistent metabolic encephalopathy, chronic respiratory failure required tracheostomy, multiorgan dysfunction and subsequent Staphylococcus pneumonia.
T127 11247-11363 Sentence denotes Due to a lack of improvement, the family requested comfort care, and he expired after 1 month of antifungal therapy.
T128 11364-11538 Sentence denotes Patient 4 was a 77‐year‐old man with a history of type 2 diabetes mellitus who was transferred to the ICU on hospital day 8 for worsening acute hypoxemic respiratory failure.
T129 11539-11733 Sentence denotes He had been on NIV for 8 days and on cefepime and vancomycin until respiratory status further deteriorated, which required intubation and transfer to the ICU 2 days before Aspergillus isolation.
T130 11734-11794 Sentence denotes He was afebrile at Aspergillus isolation on hospital day 10.
T131 11795-11851 Sentence denotes Chest radiographs showed diffuse ground‐glass opacities.
T132 11852-11915 Sentence denotes Caspofungin was started together with meropenem and vancomycin.
T133 11916-12019 Sentence denotes He continued to deteriorate with multiorgan dysfunction and expired after 3 days of antifungal therapy.
T134 12021-12034 Sentence denotes 4 DISCUSSION
T135 12035-12144 Sentence denotes Reports of pulmonary aspergillosis complicating severe COVID‐19 required mechanical ventilation are emerging.
T136 12145-12273 Sentence denotes 5 , 6 Most patients did not have underlying immunocompromising conditions, as observed in patients with ARDS due to influenza.
T137 12274-12470 Sentence denotes 2 Detailed data from patients who presented in the first waves of COVID‐19 pandemic are needed to define the incidence and clinical features of COVID‐19‐associated pulmonary aspergillosis (CAPA).
T138 12471-12591 Sentence denotes 8 We herein describe the clinical characteristics of four cases of critically ill COVID‐19 complicated by putative IPA.
T139 12592-12693 Sentence denotes Early diagnosis of IPA is critical but challenging in mechanically ventilated patients with COVID‐19.
T140 12694-12816 Sentence denotes Bronchoscopy and transbronchial biopsy are rarely performed given the risk of complications and transmission of the virus.
T141 12817-12899 Sentence denotes Further, pneumonia due to SARS‐CoV‐2 may obscure the radiological findings of IPA.
T142 12900-13087 Sentence denotes Consolidation is commonly seen in both COVID‐19 and superimposing pulmonary aspergillosis, and any new radiological signs could be obscured by background bilateral ground‐glass opacities.
T143 13088-13234 Sentence denotes Systemic inflammatory markers are almost always elevated with severe COVID‐19, which make them less useful to diagnose secondary fungal infection.
T144 13235-13492 Sentence denotes While it has been suggested that a low procalcitonin level may indicate a high likelihood for invasive fungal infection in critically ill patients with clinical signs of sepsis, 9 the procalcitonin level was elevated in only two patients with putative IPA.
T145 13493-13749 Sentence denotes At our institution, fungal cultures are routinely performed on bronchoscopy specimens and other respiratory specimens as clinically indicated; consequently, it is plausible there were instances of Aspergillus respiratory infection that were not identified.
T146 13750-13817 Sentence denotes Aspergillus infection can be seen in construction‐related clusters.
T147 13818-13989 Sentence denotes 10 While there was some construction at our institution during the first wave of COVID‐19, it was physically remote from the units where all of the cases were identified.
T148 13990-14134 Sentence denotes Further, there were no instances of isolating Aspergillus from any patients without the diagnosis of COVID‐19 within or around the study period.
T149 14135-14267 Sentence denotes For research purposes, EORTC/MSG Consensus Group have proposed definitions of proven, probable and possible invasive fungal disease.
T150 14268-14462 Sentence denotes 11 However, these consensus definitions are much less useful for immunocompetent patients in the ICU, as the diagnosis of probable or possible IPA requires the presence of classic host factors.
T151 14463-14660 Sentence denotes We used the AspICU criteria, which is an algorithm for diagnosing IPA in the ICU patients with positive Aspergillus endotracheal aspirate cultures, 7 to distinguish putative IPA from colonisation.
T152 14661-14804 Sentence denotes However, the performance characteristics of the algorithm for COVID‐19 patients have not been validated with autopsy or postmortem biopsy data.
T153 14805-14877 Sentence denotes Serum galactomannan was positive in only one patient in our case series.
T154 14878-15014 Sentence denotes Serum galactomannan is more specific for invasive aspergillosis than beta‐D‐glucan but has poor sensitivity in non‐neutropenic patients.
T155 15015-15131 Sentence denotes 12 Combining three case series of CAPA, only three (13%) out of 23 patients had positive serum galactomannan level.
T156 15132-15337 Sentence denotes 5 , 6 , 13 The less frequently elevated serum galactomannan levels might simply reflect colonisation rather than infection or suggest that angioinvasive pulmonary infection is a rare phenomenon in CAPA.
T157 15338-15425 Sentence denotes In any case, the diagnostic value of serum galactomannan for CAPA seems less promising.
T158 15426-15560 Sentence denotes All the patients with putative IPA died in our consecutive cases, suggesting the grave prognosis of critically ill patients with CAPA.
T159 15561-15740 Sentence denotes On the other hand, Alanio et al reported no significant difference in mortality between IPA and non‐IPA patients in a report of eight COVID‐19‐infected patients with putative IPA.
T160 15741-15866 Sentence denotes 6 Further data from multi‐institutional series are needed to clearly characterise the potential impact on mortality of CAPA.
T161 15867-16097 Sentence denotes Although dexamethasone was recently shown to decrease 28‐day mortality in mechanically ventilated patients with COVID‐19, 14 the majority of our cases received much higher doses of glucocorticoids than what was proven beneficial.
T162 16098-16281 Sentence denotes Since one of the potential sequelae of COVID‐19 is secondary fungal infections as our cases demonstrated, vigilance for secondary infections will be needed to reduce adverse outcomes.
T163 16282-16578 Sentence denotes Clinicians should have a high index of suspicion for CAPA when a critically ill patient with COVID‐19 in the ICU develops further respiratory decompensation, fevers or new or worsening radiographic abnormalities of the lungs, particularly if there is no response to empiric antibacterial therapy.
T164 16579-16759 Sentence denotes It is important to obtain a respiratory culture for fungal pathogens and a serum galactomannan level in these settings to attempt to identify this ominous complication of COVID‐19.
T165 16761-16782 Sentence denotes CONFLICTS OF INTEREST
T166 16783-16829 Sentence denotes There are no conflicts of interest to declare.
T167 16831-16851 Sentence denotes AUTHOR CONTRIBUTIONS
T168 16852-16866 Sentence denotes Hayato Mitaka:
T169 16867-17031 Sentence denotes Conceptualization (equal); data curation (equal); formal analysis (equal); investigation (equal); writing‐original draft (lead); writing‐review and editing (equal).
T170 17032-17040 Sentence denotes David C.
T171 17041-17049 Sentence denotes Perlman:
T172 17050-17154 Sentence denotes Conceptualization (equal); methodology (equal); supervision (equal); writing‐review and editing (equal).
T173 17155-17169 Sentence denotes Waleed Javaid:
T174 17170-17231 Sentence denotes Supervision (equal); writing‐review and editing (supporting).
T175 17232-17246 Sentence denotes Nadim Salomon:
T176 17247-17434 Sentence denotes Conceptualization (equal); data curation (equal); investigation (equal); methodology (equal); supervision (equal); writing‐original draft (supporting); writing‐review and editing (equal).
T177 17436-17463 Sentence denotes DATA AVAILABILITY STATEMENT
T178 17464-17581 Sentence denotes The data that support the findings of this study are available from the corresponding author upon reasonable request.
T179 17582-17657 Sentence denotes The data are not publicly available due to privacy or ethical restrictions.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
4 60-68 Species denotes patients Tax:9606
5 9-41 Disease denotes invasive pulmonary aspergillosis MESH:D055744
6 45-59 Disease denotes critically ill MESH:D016638
7 74-82 Disease denotes COVID‐19 MESH:C000657245
13 186-194 Species denotes patients Tax:9606
14 171-185 Disease denotes Critically ill MESH:D016638
15 200-224 Disease denotes coronavirus disease‐2019 MESH:C000657245
16 226-234 Disease denotes COVID‐19 MESH:C000657245
17 267-299 Disease denotes invasive pulmonary aspergillosis MESH:D055744
19 334-342 Species denotes Patients Tax:9606
25 527-535 Species denotes patients Tax:9606
26 555-566 Species denotes Aspergillus Tax:746128
27 397-405 Disease denotes COVID‐19 MESH:C000657245
28 417-440 Disease denotes pulmonary aspergillosis MESH:D055732
29 541-549 Disease denotes COVID‐19 MESH:C000657245
42 629-637 Species denotes patients Tax:9606
43 706-727 Species denotes Aspergillus fumigatus Tax:746128
44 803-811 Species denotes patients Tax:9606
45 882-890 Species denotes patients Tax:9606
46 906-914 Species denotes patients Tax:9606
47 1072-1079 Species denotes patient Tax:9606
48 1211-1219 Species denotes patients Tax:9606
49 997-1008 Species denotes Aspergillus Tax:746128
50 1026-1039 Chemical denotes galactomannan MESH:C012990
51 643-651 Disease denotes COVID‐19 MESH:C000657245
52 1183-1192 Disease denotes mortality MESH:D003643
53 1220-1224 Disease denotes died MESH:D003643
58 1341-1349 Species denotes patients Tax:9606
59 1270-1280 Disease denotes infections MESH:D007239
60 1326-1340 Disease denotes critically ill MESH:D016638
61 1355-1363 Disease denotes COVID‐19 MESH:C000657245
80 1457-1465 Species denotes patients Tax:9606
81 1486-1494 Species denotes Patients Tax:9606
82 1676-1684 Species denotes patients Tax:9606
83 1798-1806 Species denotes patients Tax:9606
84 1907-1915 Species denotes patients Tax:9606
85 2044-2052 Species denotes patients Tax:9606
86 1382-1414 Disease denotes Invasive pulmonary aspergillosis MESH:D055744
87 1442-1456 Disease denotes critically ill MESH:D016638
88 1500-1524 Disease denotes coronavirus disease‐2019 MESH:C000657245
89 1526-1534 Disease denotes COVID‐19 MESH:C000657245
90 1564-1583 Disease denotes respiratory failure MESH:D012131
91 1697-1705 Disease denotes COVID‐19 MESH:C000657245
92 1812-1820 Disease denotes COVID‐19 MESH:C000657245
93 1890-1903 Disease denotes aspergillosis MESH:D001228
94 1921-1929 Disease denotes COVID‐19 MESH:C000657245
95 2011-2025 Disease denotes critically ill MESH:D016638
96 2026-2043 Disease denotes COVID‐19‐infected MESH:C000657245
97 2058-2081 Disease denotes pulmonary aspergillosis MESH:D055732
99 2115-2123 Species denotes PATIENTS Tax:9606
114 2203-2211 Species denotes patients Tax:9606
115 2770-2778 Species denotes patients Tax:9606
116 2217-2228 Species denotes Aspergillus Tax:746128
117 2436-2442 Chemical denotes oxygen MESH:D010100
118 2444-2448 Chemical denotes FiO2
119 2662-2672 Chemical denotes prednisone MESH:D011241
120 3135-3139 Chemical denotes FiO2
121 2185-2202 Disease denotes COVID‐19‐infected MESH:C000657245
122 2674-2679 Disease denotes Fever MESH:D005334
123 2791-2814 Disease denotes pulmonary aspergillosis MESH:D055732
124 2919-2924 Disease denotes fever MESH:D005334
125 2940-2945 Disease denotes fever MESH:D005334
126 3019-3024 Disease denotes fever MESH:D005334
127 3192-3211 Disease denotes respiratory failure MESH:D012131
159 3393-3401 Species denotes patients Tax:9606
160 3470-3491 Species denotes Aspergillus fumigatus Tax:746128
161 3552-3560 Species denotes patients Tax:9606
162 3606-3614 Species denotes patients Tax:9606
163 3901-3908 Species denotes patient Tax:9606
164 4004-4012 Species denotes patients Tax:9606
165 4545-4553 Species denotes patients Tax:9606
166 4651-4659 Species denotes patients Tax:9606
167 4758-4766 Species denotes patients Tax:9606
168 4948-4969 Species denotes Aspergillus fumigatus Tax:746128
169 4975-4983 Species denotes patients Tax:9606
170 5247-5254 Species denotes patient Tax:9606
171 5272-5280 Species denotes patients Tax:9606
172 5066-5077 Species denotes Aspergillus Tax:746128
173 5092-5103 Species denotes Aspergillus Tax:746128
174 5171-5179 Species denotes patients Tax:9606
175 4241-4251 Chemical denotes prednisone MESH:D011241
176 5201-5214 Chemical denotes galactomannan MESH:C012990
177 3407-3415 Disease denotes COVID‐19 MESH:C000657245
178 3671-3677 Disease denotes Cancer MESH:D009369
179 3679-3705 Disease denotes Invasive Fungal Infections MESH:D000072742
180 3754-3761 Disease denotes Allergy MESH:D004342
181 3766-3785 Disease denotes Infectious Diseases MESH:D003141
182 3842-3853 Disease denotes neutropenia MESH:D009503
183 3928-3940 Disease denotes lung disease MESH:D008171
184 3942-3979 Disease denotes chronic obstructive pulmonary disease MESH:D029424
185 4035-4040 Disease denotes fever MESH:D005334
186 4107-4132 Disease denotes respiratory insufficiency MESH:D012131
187 4439-4448 Disease denotes pneumonia MESH:D011014
188 5115-5120 Disease denotes fever MESH:D005334
189 5125-5137 Disease denotes leukocytosis MESH:D007964
215 5878-5899 Species denotes Aspergillus fumigatus Tax:746128
216 5993-6004 Species denotes Aspergillus Tax:746128
217 6060-6071 Species denotes Aspergillus Tax:746128
218 6519-6529 Chemical denotes creatinine MESH:D003404
219 6705-6715 Chemical denotes prednisone MESH:D011241
220 6838-6849 Chemical denotes Tocilizumab MESH:C502936
221 6880-6888 Chemical denotes Cefepime MESH:D000077723
222 6891-6901 Chemical denotes Vancomycin MESH:D014640
223 6903-6911 Chemical denotes Cefepime MESH:D000077723
224 6914-6924 Chemical denotes Vancomycin MESH:D014640
225 6926-6935 Chemical denotes Meropenem MESH:D000077731
226 6938-6948 Chemical denotes Vancomycin MESH:D014640
227 6950-6958 Chemical denotes Cefepime MESH:D000077723
228 6961-6971 Chemical denotes Vancomycin MESH:D014640
229 6992-7004 Chemical denotes Voriconazole MESH:D065819
230 7006-7018 Chemical denotes Voriconazole MESH:D065819
231 7020-7032 Chemical denotes Voriconazole MESH:D065819
232 5581-5593 Disease denotes Hypertension MESH:D006973
233 5611-5619 Disease denotes Diabetes MESH:D003920
234 5637-5660 Disease denotes Coronary artery disease MESH:D003324
235 5678-5715 Disease denotes Chronic obstructive pulmonary disease MESH:D029424
236 5744-5768 Disease denotes cerebrovascular accident MESH:D020521
237 5797-5803 Disease denotes cancer MESH:D009369
238 6015-6020 Disease denotes Fever MESH:D005334
239 6224-6233 Disease denotes pneumonia MESH:D011014
244 5407-5415 Species denotes patients Tax:9606
245 5374-5388 Disease denotes critically ill MESH:D016638
246 5389-5406 Disease denotes COVID‐19‐infected MESH:C000657245
247 5430-5462 Disease denotes invasive pulmonary aspergillosis MESH:D055744
249 7223-7231 Disease denotes COVID-19 MESH:C000657245
260 7458-7466 Species denotes patients Tax:9606
261 7654-7661 Species denotes patient Tax:9606
262 7663-7671 Species denotes patients Tax:9606
263 7912-7919 Species denotes patient Tax:9606
264 7620-7631 Species denotes Aspergillus Tax:746128
265 7719-7730 Species denotes Aspergillus Tax:746128
266 7947-7958 Species denotes Aspergillus Tax:746128
267 7546-7554 Chemical denotes steroids MESH:D013256
268 7850-7860 Chemical denotes prednisone MESH:D011241
269 7929-7940 Chemical denotes tocilizumab MESH:C502936
284 8193-8204 Species denotes Aspergillus Tax:746128
285 8489-8500 Species denotes Aspergillus Tax:746128
286 8286-8290 Chemical denotes FiO2
287 8397-8405 Chemical denotes cefepime MESH:D000077723
288 8410-8420 Chemical denotes vancomycin MESH:D014640
289 8422-8434 Chemical denotes Voriconazole MESH:D065819
290 8559-8571 Chemical denotes voriconazole MESH:D065819
291 8033-8037 Disease denotes COPD MESH:D029424
292 8053-8059 Disease denotes cancer MESH:D009369
293 8113-8148 Disease denotes acute respiratory distress syndrome MESH:D012128
294 8150-8154 Disease denotes ARDS MESH:D012128
295 8160-8172 Disease denotes septic shock MESH:D012772
296 8502-8514 Disease denotes Leukocytosis MESH:D007964
297 8599-8604 Disease denotes fever MESH:D005334
315 9258-9279 Species denotes Aspergillus fumigatus Tax:746128
316 9284-9305 Species denotes Staphylococcus aureus Tax:1280
317 9192-9203 Species denotes Aspergillus Tax:746128
318 9559-9570 Species denotes Aspergillus Tax:746128
319 9474-9482 Chemical denotes cefepime MESH:D000077723
320 9487-9497 Chemical denotes vancomycin MESH:D014640
321 9499-9511 Chemical denotes Voriconazole MESH:D065819
322 9696-9705 Chemical denotes meropenem MESH:D000077731
323 9707-9717 Chemical denotes vancomycin MESH:D014640
324 9723-9735 Chemical denotes voriconazole MESH:D065819
325 8871-8883 Disease denotes hypertension MESH:D006973
326 8885-8908 Disease denotes coronary artery disease MESH:D003324
327 8942-8962 Disease denotes renal cell carcinoma MESH:C538614
328 9042-9061 Disease denotes respiratory failure MESH:D012131
329 9425-9442 Disease denotes pneumopericardium MESH:D011026
330 9781-9793 Disease denotes leukocytosis MESH:D007964
331 9829-9851 Disease denotes multiorgan dysfunction MESH:D009102
352 10091-10102 Species denotes Aspergillus Tax:746128
353 11221-11235 Species denotes Staphylococcus Tax:1280
354 10203-10212 Chemical denotes meropenem MESH:D000077731
355 10217-10227 Chemical denotes vancomycin MESH:D014640
356 10261-10273 Chemical denotes voriconazole MESH:D065819
357 10580-10592 Chemical denotes voriconazole MESH:D065819
358 10681-10693 Chemical denotes voriconazole MESH:D065819
359 11042-11052 Chemical denotes vancomycin MESH:D014640
360 10025-10044 Disease denotes respiratory failure MESH:D012131
361 10082-10087 Disease denotes fever MESH:D005334
362 10229-10234 Disease denotes Fever MESH:D005334
363 10599-10604 Disease denotes Fever MESH:D005334
364 10609-10621 Disease denotes leukocytosis MESH:D007964
365 10779-10788 Disease denotes pneumonia MESH:D011014
366 10958-10974 Disease denotes thrombophlebitis MESH:D013924
367 10995-11017 Disease denotes epidermidis bacteremia MESH:D016470
368 11106-11130 Disease denotes metabolic encephalopathy MESH:D001928
369 11140-11159 Disease denotes respiratory failure MESH:D012131
370 11183-11205 Disease denotes multiorgan dysfunction MESH:D009102
371 11236-11245 Disease denotes pneumonia MESH:D011014
382 11711-11722 Species denotes Aspergillus Tax:746128
383 11753-11764 Species denotes Aspergillus Tax:746128
384 11576-11584 Chemical denotes cefepime MESH:D000077723
385 11589-11599 Chemical denotes vancomycin MESH:D014640
386 11852-11863 Chemical denotes Caspofungin MESH:D000077336
387 11890-11899 Chemical denotes meropenem MESH:D000077731
388 11904-11914 Chemical denotes vancomycin MESH:D014640
389 11414-11438 Disease denotes type 2 diabetes mellitus MESH:D003924
390 11518-11537 Disease denotes respiratory failure MESH:D012131
391 11949-11971 Disease denotes multiorgan dysfunction MESH:D009102
403 12158-12166 Species denotes patients Tax:9606
404 12237-12245 Species denotes patients Tax:9606
405 12296-12304 Species denotes patients Tax:9606
406 12046-12069 Disease denotes pulmonary aspergillosis MESH:D055732
407 12090-12098 Disease denotes COVID‐19 MESH:C000657245
408 12251-12255 Disease denotes ARDS MESH:D012128
409 12341-12349 Disease denotes COVID‐19 MESH:C000657245
410 12419-12427 Disease denotes COVID‐19 MESH:C000657245
411 12439-12462 Disease denotes pulmonary aspergillosis MESH:D055732
412 12539-12553 Disease denotes critically ill MESH:D016638
413 12554-12562 Disease denotes COVID‐19 MESH:C000657245
427 12670-12678 Species denotes patients Tax:9606
428 12843-12853 Species denotes SARS‐CoV‐2 Tax:2697049
429 13373-13381 Species denotes patients Tax:9606
430 13465-13473 Species denotes patients Tax:9606
431 12684-12692 Disease denotes COVID‐19 MESH:C000657245
432 12826-12835 Disease denotes pneumonia MESH:D011014
433 12939-12947 Disease denotes COVID‐19 MESH:C000657245
434 12966-12989 Disease denotes pulmonary aspergillosis MESH:D055732
435 13157-13165 Disease denotes COVID‐19 MESH:C000657245
436 13224-13233 Disease denotes infection MESH:D007239
437 13329-13354 Disease denotes invasive fungal infection MESH:D000072742
438 13358-13372 Disease denotes critically ill MESH:D016638
439 13405-13411 Disease denotes sepsis MESH:D018805
446 14057-14065 Species denotes patients Tax:9606
447 14036-14047 Species denotes Aspergillus Tax:746128
448 13690-13723 Disease denotes Aspergillus respiratory infection MESH:D012141
449 13750-13771 Disease denotes Aspergillus infection MESH:D001228
450 13900-13908 Disease denotes COVID‐19 MESH:C000657245
451 14091-14099 Disease denotes COVID‐19 MESH:C000657245
458 14350-14358 Species denotes patients Tax:9606
459 14544-14552 Species denotes patients Tax:9606
460 14732-14740 Species denotes patients Tax:9606
461 14567-14578 Species denotes Aspergillus Tax:746128
462 14243-14258 Disease denotes invasive fungal MESH:D000072742
463 14723-14731 Disease denotes COVID‐19 MESH:C000657245
476 14850-14857 Species denotes patient Tax:9606
477 15005-15013 Species denotes patients Tax:9606
478 15083-15091 Species denotes patients Tax:9606
479 14811-14824 Chemical denotes galactomannan MESH:C012990
480 14884-14897 Chemical denotes galactomannan MESH:C012990
481 14947-14960 Chemical denotes beta‐D‐glucan
482 15111-15124 Chemical denotes galactomannan MESH:C012990
483 15181-15194 Chemical denotes galactomannan MESH:C012990
484 15381-15394 Chemical denotes galactomannan MESH:C012990
485 14919-14941 Disease denotes invasive aspergillosis MESH:D055744
486 15248-15257 Disease denotes infection MESH:D007239
487 15274-15307 Disease denotes angioinvasive pulmonary infection MESH:D012141
509 15434-15442 Species denotes patients Tax:9606
510 15541-15549 Species denotes patients Tax:9606
511 15665-15673 Species denotes patients Tax:9606
512 15713-15721 Species denotes patients Tax:9606
513 15965-15973 Species denotes patients Tax:9606
514 16362-16369 Species denotes patient Tax:9606
515 15876-15889 Chemical denotes dexamethasone MESH:D003907
516 16660-16673 Chemical denotes galactomannan MESH:C012990
517 15461-15465 Disease denotes died MESH:D003643
518 15526-15540 Disease denotes critically ill MESH:D016638
519 15631-15640 Disease denotes mortality MESH:D003643
520 15695-15712 Disease denotes COVID‐19‐infected MESH:C000657245
521 15848-15857 Disease denotes mortality MESH:D003643
522 15928-15937 Disease denotes mortality MESH:D003643
523 15979-15987 Disease denotes COVID‐19 MESH:C000657245
524 16137-16145 Disease denotes COVID‐19 MESH:C000657245
525 16166-16176 Disease denotes infections MESH:D007239
526 16228-16238 Disease denotes infections MESH:D007239
527 16347-16361 Disease denotes critically ill MESH:D016638
528 16375-16383 Disease denotes COVID‐19 MESH:C000657245
529 16750-16758 Disease denotes COVID‐19 MESH:C000657245